NGAL as a Biomarker of Tubular Injury and Glomerular Dysfunction in Fabry Nephropathy
- 1Lysosomal and Rare Disorders Research and Treatment Center, Fairfax, VA 22030, USA
Abstract
Fabry disease (FD) is an X-linked lysosomal disorder caused by pathogenic variants in the GLA gene, resulting in α-galactosidase A deficiency and accumulation of Gb3/lyso-Gb3 (globotriaosylceramide/globotriaosylsphingosine) in cells, including podocytes and renal tubular cells. While podocyte damage drives glomerular dysfunction, tubular dysfunction leads to atrophy and fibrosis, often preceding a detectable decline in glomerular filtration rate (eGFR). Neutrophil gelatinase-associated lipocalin (NGAL) is a marker of renal injury, with urinary and plasma NGAL reflecting distinct aspects of renal dysfunction; however, their clinical value in Fabry nephropathy (FN) remains poorly defined. We explored the clinical relevance of NGAL in distinguishing tubular atrophy from glomerular podocytopathy. Thirty-three FD patients were categorized into groups without and with FN using eGFR. In males, elevated NGAL strongly correlated with FN. In females, urine NGAL was increased regardless of nephropathy status, while plasma NGAL rose mainly in those with reduced eGFR. This pattern suggests that tubular damage and early tubulointerstitial fibrosis (TIF) may precede glomerular impairment in female patients. Conclusions: Tubular damage may precede glomerular dysfunction in FD, and NGAL may serve as a sensitive biomarker of early tubular injury, including before overt nephropathy. NGAL may provide complementary, noninvasive tools for detecting and monitoring renal involvement in Fabry disease.
Related
- Huaier Attenuates Renal Injury in Type 2 Diabetic Nephropathy by Ameliorating Mitochondrial Dysfunction and Inhibiting Tubular Epithelial Cell Apoptosis.
- Deep visual proteomics reveals distinct proximal tubular and glomerular injury programs in experimental diabetic kidney disease
- Acute Kidney Injury in Childhood Nephrotic Syndrome: From Hemodynamic Vulnerability and Tubular Stress Toward Biomarker-Guided Management.
- Glomerular Properdin Deposition Suggests a Favorable Therapeutic Response to Tonsillectomy and Steroid Pulse Therapy in IgA Nephropathy
- Correlation of Glomerular MBL Deposition with the Clinicopathology and Prognosis of Idiopathic Membranous Nephropathy: A PLA2R Subgroup Analysis.
BibTeX
@article{ivanova2026ngal,
title = {{NGAL as a Biomarker of Tubular Injury and Glomerular Dysfunction in Fabry Nephropathy}},
author = {Margarita M. Ivanova and Julia Dao and Leah Svarny and Emily Nguyen and Sahithi Ponnam and Ozlem Goker-Alpan},
journal = {Cells},
year = {2026},
month = oct,
doi = {10.3390/cells15191797},
url = {https://www.mdpi.com/2073-4409/15/19/1797},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - NGAL as a Biomarker of Tubular Injury and Glomerular Dysfunction in Fabry Nephropathy
AU - Margarita M. Ivanova
AU - Julia Dao
AU - Leah Svarny
AU - Emily Nguyen
AU - Sahithi Ponnam
AU - Ozlem Goker-Alpan
PY - 2026
DA - 2026/10/01
JO - Cells
DO - 10.3390/cells15191797
UR - https://www.mdpi.com/2073-4409/15/19/1797
AB - Fabry disease (FD) is an X-linked lysosomal disorder caused by pathogenic variants in the GLA gene, resulting in α-galactosidase A deficiency and accumulation of Gb3/lyso-Gb3 (globotriaosylceramide/globotriaosylsphingosine) in cells, including podocytes and renal tubular cells. While podocyte damage drives glomerular dysfunction, tubular dysfunction leads to atrophy and fibrosis, often preceding a detectable decline in glomerular filtration rate (eGFR). Neutrophil gelatinase-associated lipocalin (NGAL) is a marker of renal injury, with urinary and plasma NGAL reflecting distinct aspects of renal dysfunction; however, their clinical value in Fabry nephropathy (FN) remains poorly defined. We explored the clinical relevance of NGAL in distinguishing tubular atrophy from glomerular podocytopathy. Thirty-three FD patients were categorized into groups without and with FN using eGFR. In males, elevated NGAL strongly correlated with FN. In females, urine NGAL was increased regardless of nephropathy status, while plasma NGAL rose mainly in those with reduced eGFR. This pattern suggests that tubular damage and early tubulointerstitial fibrosis (TIF) may precede glomerular impairment in female patients. Conclusions: Tubular damage may precede glomerular dysfunction in FD, and NGAL may serve as a sensitive biomarker of early tubular injury, including before overt nephropathy. NGAL may provide complementary, noninvasive tools for detecting and monitoring renal involvement in Fabry disease.
SN - 2073-4409
ER -